company background image
IQAI

IQ-AI LSE:IQAI Stock Report

Last Price

UK£0.029

Market Cap

UK£5.3m

7D

-2.5%

1Y

-50.2%

Updated

30 Jan, 2023

Data

Company Financials

IQAI Stock Overview

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States.

IQAI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

IQ-AI Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IQ-AI
Historical stock prices
Current Share PriceUK£0.029
52 Week HighUK£0.061
52 Week LowUK£0.015
Beta2.9
1 Month Change60.27%
3 Month Change36.05%
1 Year Change-50.21%
3 Year Change-28.66%
5 Year Change-31.18%
Change since IPO-19.31%

Recent News & Updates

Recent updates

IQ-AI (LON:IQAI) Is In A Good Position To Deliver On Growth Plans

Feb 08
IQ-AI (LON:IQAI) Is In A Good Position To Deliver On Growth Plans

Have IQ-AI Limited (LON:IQAI) Insiders Been Selling Their Stock?

Dec 09
Have IQ-AI Limited (LON:IQAI) Insiders Been Selling Their Stock?

Shareholder Returns

IQAIGB Healthcare ServicesGB Market
7D-2.5%-0.7%0.005%
1Y-50.2%-7.6%-4.5%

Return vs Industry: IQAI underperformed the UK Healthcare Services industry which returned -10.7% over the past year.

Return vs Market: IQAI underperformed the UK Market which returned -4.8% over the past year.

Price Volatility

Is IQAI's price volatile compared to industry and market?
IQAI volatility
IQAI Average Weekly Movement11.3%
Healthcare Services Industry Average Movement3.7%
Market Average Movement5.1%
10% most volatile stocks in GB Market11.0%
10% least volatile stocks in GB Market2.7%

Stable Share Price: IQAI is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: IQAI's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a7Trevor Brownhttps://www.imagingbiometrics.com/iq-ai-ltd

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient’s kidney stone.

IQ-AI Limited Fundamentals Summary

How do IQ-AI's earnings and revenue compare to its market cap?
IQAI fundamental statistics
Market CapUK£5.34m
Earnings (TTM)-UK£624.51k
Revenue (TTM)UK£538.19k

9.9x

P/S Ratio

-8.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IQAI income statement (TTM)
RevenueUK£538.19k
Cost of RevenueUK£10.52k
Gross ProfitUK£527.67k
Other ExpensesUK£1.15m
Earnings-UK£624.51k

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0034
Gross Margin98.05%
Net Profit Margin-116.04%
Debt/Equity Ratio0%

How did IQAI perform over the long term?

See historical performance and comparison